在原子层面上对人类P-糖蛋白的基质流量进行建模
Yingjie Gao1, Yang Tang1, Caiyan Wei1
1Green Pharmaceutical Technology Key Laboratory of Luzhou City, Department of Medicinal Chemistry, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Journal of biomolecular structure & dynamics
|March 7, 2025
概括
人类P-葡萄糖蛋白 (hP-gp) 积极地从细胞中去除药物,导致多种药物耐药性. 模拟揭示了不同的药物是如何排放的,确定了关键的分子运动和开发更好的癌症疗法的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 人类P-葡萄糖蛋白 (hP-gp) 是一种ATP结合盒 (ABC) 载体,对外来生物流动至关重要.
- hP-gp对癌症的多药性耐药性 (MDR) 有着显著的贡献,限制了治疗疗效.
- 通过hP-gp进行基质转位的精确原子层机制仍然不完全理解.
研究的目的:
- 通过使用计算模拟,阐明hP-gp的基质转位的分子机制.
- 确定分子特征和途径,以促进各种化合物从细胞中排出.
- 为合理设计hP-gp抑制剂提供见解.
主要方法:
- 用导向分子动力学 (SMD) 模拟来研究hP-gp的排泄机制.
- 使用潜在的平均力 (PMF) 分析来确定转移的能量景观.
- 结构动力学分析检查了基板运输过程中的结构变化.
主要成果:
- 温克里斯的转位受到跨膜螺旋1 (TM1) 的曲的支持.
- 塔里基达尔的高灵活性使人能够通过狭窄的出口道,这表明门的打开机制不是通用的.
- 有证据表明,ATP的交替位点水解机制,通过保存的盐桥来为TM10过渡和域间通信提供动力.
结论:
- 对于不同的基质,hP-gp利用了不同的转位途径和分子动力学.
- ATP水解可能驱动药物排放所必需的关键形状变化.
- 这些发现提供了对hP-gp功能和克服MDR的潜在策略的更深入的理解.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
23
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
23
Carrier-Mediated Transport
228
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
228
The Significance of Membrane Transport
21.4K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
21.4K
Hepatic Drug Clearance: Role of Transporters
31
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
31
Physiological Pharmacokinetic Models: Assumption with Protein Binding
29
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
29


